Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia

McCubrey, James A.2022-02-042022-02-042016-11-031949-2553http://hdl.handle.net/10342/9629en-USNUP214-ABL1PI3K/Akt/mTOR signalingT-Acute Lymphoblastic LeukemiaSynergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic LeukemiaArticle10.18632/oncotarget.13035